Fulgent Genetics Analyst Ratings
BenzingaMar 6 09:31 ET
Piper Sandler Sticks to Its Hold Rating for Fulgent Genetics (FLGT)
TipRanksMar 6 07:36 ET
UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating
MT NewswiresFeb 29 13:00 ET
UBS Initiates Coverage On Fulgent Genetics With Neutral Rating, Announces Price Target of $35
BenzingaDec 7, 2023 06:06 ET
Fulgent Genetics Analyst Ratings
BenzingaDec 7, 2023 06:04 ET
Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $28
BenzingaOct 16, 2023 13:25 ET
Fulgent Genetics Analyst Ratings
BenzingaOct 16, 2023 13:24 ET
Piper Sandler Sticks to Their Hold Rating for Fulgent Genetics (FLGT)
TipRanksMay 8, 2023 08:42 ET
Credit Suisse Lowers Fulgent Genetics' Price Target to $45 From $50 After Mixed Q4 Results, Keeps Outperform Rating
MT NewswiresMar 2, 2023 09:51 ET
Credit Suisse Maintains Outperform on Fulgent Genetics, Lowers Price Target to $45
BenzingaMar 2, 2023 06:43 ET
Fulgent Genetics (FLGT) Gets a Buy From Raymond James
TipRanksMar 1, 2023 06:12 ET
Fulgent Genetics Analyst Ratings
Benzinga Analyst RatingsDec 8, 2022 05:14 ET
Piper Sandler Downgrades Fulgent Genetics to Neutral, Lowers Price Target to $40
Benzinga Real-time NewsDec 8, 2022 05:14 ET
Fulgent Genetics Analyst Ratings
Benzinga Analyst RatingsNov 18, 2022 07:32 ET
Raymond James Initiates Coverage On Fulgent Genetics With Outperform Rating, Announces Price Target of $45
Benzinga Real-time NewsNov 18, 2022 07:31 ET
Credit Suisse Adjusts Fulgent Genetics' Price Target to $50 From $65, Keeps Outperform Rating
MT NewswiresNov 14, 2022 11:00 ET
Fulgent Genetics Analyst Ratings
Benzinga Analyst RatingsNov 14, 2022 06:48 ET
Piper Sandler Maintains Overweight on Fulgent Genetics, Lowers Price Target to $65
Benzinga Real-time NewsNov 14, 2022 06:48 ET
Fulgent Genetics Initiated at Outperform by Credit Suisse
Dow JonesAug 25, 2022 05:45 ET
Fulgent Genetics Analyst Ratings
Benzinga Analyst RatingsAug 25, 2022 05:36 ET
No Data
No Data